Literature DB >> 9070177

Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery.

C Chen1, S R Hanson, L K Keefer, J E Saavedra, K M Davies, T C Hutsell, J D Hughes, D N Ku, A B Lumsden.   

Abstract

To evaluate the direct effect of nitric oxide (NO) on vascular smooth muscle cell (SMC) proliferation in vivo, we used an expanded polytetrafluoroethylene (ePTFE)-based local infusion device to deliver an NO donor, proline/NO (PROLI/NO), to the luminal boundary layer of endarterectomized artery and the distal anastomosis of the graft in a canine model. Once delivered to the blood, PROLI/NO releases NO by a mechanism involving pH-dependent decomposition. Six dogs underwent bilateral femoral artery endarterectomies. ePTFE infusion devices, blindly primed with PROLI/NO to one artery or proline to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. PROLI/NO or proline was continuously delivered for 7 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 7 days, and the processed specimens were blindly analyzed for SMC proliferation at both graft anastomoses and endarterectomized segments by a bromodeoxyuridine index assay. All dogs survived with no clinical side effects. In comparing the treated and control vessels, NO released from PROLI/NO significantly reduced SMC proliferation by 43% (13.24 +/- 1.24% versus 23.24 +/- 1.01%, P = 0.004) at the distal anastomoses and by 68% (10.58 +/- 1.63% versus 25.17 +/- 3.39%, P = 0.007) at endarterectomized segments. However, there was no significant difference in blood flow measurements between treated and control arteries (56.25 +/- 6.50 ml/min versus 46.50 +/- 3.20 ml/min, P = 0.094). These data demonstrate that local boundary layer infusion of NO released from PROLI/NO significantly reduces SMC proliferation in injured arteries with no effect on regional blood flow. This study suggests a new strategy to inhibit early SMC proliferation in injured arteries and probably to control intimal hyperplastic lesion formation in the manipulated vessels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070177     DOI: 10.1006/jsre.1996.4915

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

2.  Does really previous stenting affect graft patency following CABG? A 5-year follow-up: The effect of PCI on graft survival.

Authors:  Murat Çetin Songur; Sertan Özyalçin; Anıl Özen; Erdal Şimşek; Ümit Kervan; İrfan Taşoğlu; Sadi Kaplan; Kenan Köse; Ahmet Tulga Ulus
Journal:  Heart Vessels       Date:  2015-01-31       Impact factor: 2.037

3.  Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats.

Authors:  Monica P Rodriguez; Nick D Tsihlis; Zachary M Emond; Zheng Wang; Vinit N Varu; Qun Jiang; Janet M Vercammen; Melina R Kibbe
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

4.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

5.  Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

Authors:  Sadaf S Ahanchi; Vinit N Varu; Nick D Tsihlis; Janet Martinez; Charles G Pearce; Muneera R Kapadia; Qun Jiang; Joseph E Saavedra; Larry K Keefer; Joseph A Hrabie; Melina R Kibbe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

6.  V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.

Authors:  Wei Qu; Jie Liu; Anna L Dill; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Sci       Date:  2008-12-15       Impact factor: 6.716

7.  Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?

Authors:  Priscilla Henno; Christelle Maurey; Françoise Le Pimpec-Barthes; Philippe Devillier; Christophe Delclaux; Dominique Israël-Biet
Journal:  Respir Res       Date:  2015-03-28

8.  Synthesis and Characterization of Controlled Nitric Oxide Release from S-Nitroso-N-Acetyl-d-Penicillamine Covalently Linked to Polyvinyl Chloride (SNAP-PVC).

Authors:  Sean P Hopkins; Megan C Frost
Journal:  Bioengineering (Basel)       Date:  2018-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.